|
Diffuse Large B Cell Lymphoma (DLBCL) is a prevalent form of blood cancer, with a devasting survival rate of three years. Current treatments begin with aggressive chemotherapy, yet a percentage of…
Date
May 4th, 2023 Speaker
Tristan Szapary, UG '24 Department
Molecular Biology
|
|
Construction and Characterization of an Anti-CTLA4 and PD-1 Bispecific Antibody for Cancer
Date
July 30th, 2021 Speaker
Kim Tran Department
Department of Cancer Immunology and Virology, Dana Farber Cancer Institute
|
|
Comparing Routes of Administration of CAR-T Cell Therapy in Glioblastoma Mouse Models
Date
July 29th, 2021 Speaker
Tristan Szapary Department
Department of Neurosurgery, UPENN
|
|
“SARS-CoV-2: Can we test our way out of this?” Abstract: The world wasn’t prepared for SARS-CoV-2. The public health infrastructure required to detect and stop global spread of a…
Date
September 9th, 2020 Speaker
Michael Mina, Ph.D. Department
Molecular Biology Location
Zoom Webinar
|